Rick Bierly

Biography

 Rick Bierly was appointed to our Board in August, 2016. Previously, he served as Vice President and Chief Financial Officer of Medivation, Inc., a Nasdaq-listed biopharmaceutical company, for over two years prior to his retirement in July 2016. Prior to joining Medivation, Mr. Bierly served as an Executive Director in Ernst & Young LLP's Financial Accounting Advisory Services practice for life sciences and other clients. Mr. Bierly also worked more than twelve years in several leadership roles at Johnson & Johnson (JNJ), including as Vice President, Global Finance Services, Vice President, Finance of Centocor, Inc., and as Vice President, Finance, of Ortho Biotech LP (both subsidiaries of JNJ). Before joining JNJ, he held various staff and leadership positions in finance and accounting at Aventis, SmithKline and Ernst & Young LLP. He received a bachelor of business administration degree from Pennsylvania State University and is a certified public accountant in Pennsylvania (inactive) and New Jersey (inactive). Mr. Bierly has over 30 years’ experience in the pharmaceutical/biotechnology industry, and he also serves on the board of directors of Aclaris Therapeutics.

Research Interest

 Health services